EKO SENSORA: Detecting Clinically Significant Murmurs
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.
Sponsor: Corewell Health South
You may qualify if…
- ✓ Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope.
- ✓ Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography
You may not qualify if…
- ✕ Contact isolation patients
- ✕ Pediatric patients under the age of 18
Where it's recruiting
Saint Joseph
Source: ClinicalTrials.gov · NCT06155643 · last updated 2026-07-20